<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every third day (ETD; on Days 1 and 4) with vehicle solution, or the indicated doses of G-CSF or G-CSF/IgG1-FcL. On day 6 blood samples were obtained from the mice and the number of neutrophils (PMN), white blood cells (WBC), red blood cells (RBC), platelets, and lymphocytes (Lymphs) was determined. On day 6 the animals were sacrificed, their spleens weighed and the ratio of myeloid to erythroid cells (M: E ratio) in sections of the bone marrow determined. Blood and tissue samples were obtained from untreated mice on Day 1. Data are means ± SE for 5 mice per group. <sup>a</sup>p≤0.05 versus untreated controls; <sup>b</sup>p≤0.05 versus G-CSF.</p
<p>(A) Myeloid populations in the blood were monitored by flow cytometry following B16F10 tumor grow...
<p>Each value represents the mean ± SD (n = 12).</p><p>*<i>p</i><0.05 vs. 5-Fu,1 day before injectio...
<p>The experimental outlines are indicated (A), (E). Mice were treated with saline (n = 12), G-CSF (...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every other day (EOD; on Day...
<p>Mice received a subcutaneous injection every day for 5 days with vehicle solution, or the indicat...
<p>WT or Robo4-mutant mice were treated with G-CSF for 5days. BM and peripheral blood (PB) were harv...
<p>Mice were identified as moderate (<10<sup>6</sup> cfu/gm) or super-shedder (>10<sup>8</sup> cfu/g...
<p>Donor mice were injected (sc) with 200 mg/kg of GT3, then G-CSF antibody or isotype (1,000 µg/mou...
<p>Rats were made neutropenic by injection of cyclophosphamide (CPA) on Day 0. Beginning on Day 1 an...
<p><b>(A)</b> GKO mice were depleted of G-CSF or neutrophils with 3 doses of αG-CSF or αLy6G Ab (250...
<p>(A) Mice were immunized in the footpad with SIINFEKL and CFA and frequencies and total number of ...
<p>Compared to vehicle treatment in rats with CCI, G-CSF treatment in rats with CCI significant incr...
<p>Experimental outline for measuring the PB-RBC counts of mice treated with G-CSF (n = 8) or EPO (n...
<p>(A–F) Female NZB/W F1 mice at 5–6 months of age were treated with anti-CD20 (1 mg mg/mouse), anti...
<p>A,B: Mice were identified as moderate (<10<sup>6</sup> cfu/gm) or super-shedder (>10<sup>8</sup> ...
<p>(A) Myeloid populations in the blood were monitored by flow cytometry following B16F10 tumor grow...
<p>Each value represents the mean ± SD (n = 12).</p><p>*<i>p</i><0.05 vs. 5-Fu,1 day before injectio...
<p>The experimental outlines are indicated (A), (E). Mice were treated with saline (n = 12), G-CSF (...
<p>Mice received subcutaneous injections every day (ED; on Days 1–5) or every other day (EOD; on Day...
<p>Mice received a subcutaneous injection every day for 5 days with vehicle solution, or the indicat...
<p>WT or Robo4-mutant mice were treated with G-CSF for 5days. BM and peripheral blood (PB) were harv...
<p>Mice were identified as moderate (<10<sup>6</sup> cfu/gm) or super-shedder (>10<sup>8</sup> cfu/g...
<p>Donor mice were injected (sc) with 200 mg/kg of GT3, then G-CSF antibody or isotype (1,000 µg/mou...
<p>Rats were made neutropenic by injection of cyclophosphamide (CPA) on Day 0. Beginning on Day 1 an...
<p><b>(A)</b> GKO mice were depleted of G-CSF or neutrophils with 3 doses of αG-CSF or αLy6G Ab (250...
<p>(A) Mice were immunized in the footpad with SIINFEKL and CFA and frequencies and total number of ...
<p>Compared to vehicle treatment in rats with CCI, G-CSF treatment in rats with CCI significant incr...
<p>Experimental outline for measuring the PB-RBC counts of mice treated with G-CSF (n = 8) or EPO (n...
<p>(A–F) Female NZB/W F1 mice at 5–6 months of age were treated with anti-CD20 (1 mg mg/mouse), anti...
<p>A,B: Mice were identified as moderate (<10<sup>6</sup> cfu/gm) or super-shedder (>10<sup>8</sup> ...
<p>(A) Myeloid populations in the blood were monitored by flow cytometry following B16F10 tumor grow...
<p>Each value represents the mean ± SD (n = 12).</p><p>*<i>p</i><0.05 vs. 5-Fu,1 day before injectio...
<p>The experimental outlines are indicated (A), (E). Mice were treated with saline (n = 12), G-CSF (...